“[We] see a developing potential for nearly a total control of human emotional status, mental functioning, and will to act.” Psychiatrist Wayne O. Evans 1967
Their plan? …to create by the year 2000 a range of psychiatric drugs regulating every aspect of human behavior. 100,000,000 people worldwide are on psychiatric drugs. How did this happen? Psychiatrists convinced them they were sick. While generating a healthy income claiming to be medical professionals, psychiatrists will freely confess that their profession is devoid of science.
“We don’t really have any specific blood tests, or other tests that are definitive for any mental illness whatsoever.” New Jersey Psychiatrist
“It would be neat if it would become much more scientific.” Pennsylvania Psychiatrist
“Well if you go to my office and you tell me that your depressed, there is nothing and no blood sample or whatever… no tests.” Mexico Psychiatrist
“There are no current available tests to verify your diagnosis.” Greece Psychiatrist
“I don’t use any tests.” Massachusetts Psychiatrist
“You do not have a test to say, well it is this disorder and this is the best medication for this disorder.” Germany Psychiatrist
“For many years we thought we had the tests nailed down, but it turned out that they weren’t of any value.” Michigan Psychiatrist
Everyday, psychotropic drugs cause serious adverse reactions. And, while psychiatrists and drug companies fully understand that dangers of the drugs they sell, their unsuspecting customers are left to suffer the consequences.
How do you market a drug that restores the chemical balance, or corrects a chemical imbalance in good conscious if you don’t even know what one is?
An estimated half of all Americans who commit suicide are on psychotropic drugs. Annually, psychotropic drugs are estimated to kill more than 2 1/2 times more people than are killed by homicide. And who is entrusted with protecting the public against these dangerous psychotropic drugs? In the United States it is the Food and Drug Administration, FDA, whose psychiatric drug advisory panels are dominated by psychiatrists who shuttle between the drug industry, academia, private practice, and government. The so called “revolving door”.
The panels that are formed by the FDA to evaluate these drugs, the psychiatrists who are on those panels, almost all of them have conflicts of interest where they have directly or indirectly received funding from the very industry and the very parties within the industry, whose drugs they are evaluating.
Take for example the FDA drug evaluation panel, that approved the anti depressant Paxil. Every psychiatrist on that panel has financial ties to the pharmaceutical industry. And these conflicts of interest have been random enough to prompt congressional investigation.
And this network of financial conflict of interests between psychiatry, the drug industry, and the FDA, became even more entrenched in 1992 after passage of the Prescription Drug User Fee Act, also known as PDUFA. Through this bill the FDA would be paid a fee of $100,000 dollars per drug to ensure that psychotropic medications would be rushed through the approval process and into the hands of prescribers faster than ever.